<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pharmjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Разработка и регистрация лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Drug development &amp; registration</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2305-2066</issn><issn pub-type="epub">2658-5049</issn><publisher><publisher-name>LLC «CPHA»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">pharmjournal-582</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АНАЛИТИЧЕСКИЕ МЕТОДИКИ И МЕТОДЫ КОНТРОЛЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ANALYTICAL AND QUALITY CONTROL METHODS</subject></subj-group></article-categories><title-group><article-title>К ВОПРОСУ О СИНТЕЗЕ И СТАНДАРТИЗАЦИИ БИОЛОГИЧЕСКИ АКТИВНЫХ ПРОИЗВОДНЫХ ПИРИДИНА И ПИРРОЛА</article-title><trans-title-group xml:lang="en"><trans-title>TO THE QUESTION OF SYNTHESIS AND STANDARDIZATION OF PHARMACOLOGICALLY ACTIVE PYRIDINE AND PYRROLE DERIVATIVES</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Комесс</surname><given-names>С.</given-names></name><name name-style="western" xml:lang="en"><surname>Comesse</surname><given-names>S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шампеттер</surname><given-names>Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Champetter</surname><given-names>Ph.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Саркисян</surname><given-names>З. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Sarkissyan</surname><given-names>Z. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карасавиди</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Karasavidi</surname><given-names>A. O.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кириллова</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kirillova</surname><given-names>E. N.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Булангас</surname><given-names>С.</given-names></name><name name-style="western" xml:lang="en"><surname>Bulangas</surname><given-names>S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Университет Гавра</institution></aff><aff xml:lang="en"><institution>Université du Havre</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Санкт-Петербургский государственный химико-фармацевтический университет»</institution></aff><aff xml:lang="en"><institution>Saint-Petersburg State Chemical and Pharmaceutical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>09</day><month>01</month><year>2019</year></pub-date><volume>0</volume><issue>2</issue><fpage>84</fpage><lpage>85</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Комесс С., Шампеттер Ф., Саркисян З.М., Карасавиди А.О., Кириллова Е.Н., Булангас С., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Комесс С., Шампеттер Ф., Саркисян З.М., Карасавиди А.О., Кириллова Е.Н., Булангас С.</copyright-holder><copyright-holder xml:lang="en">Comesse S., Champetter P., Sarkissyan Z.M., Karasavidi A.O., Kirillova E.N., Bulangas S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmjournal.ru/jour/article/view/582">https://www.pharmjournal.ru/jour/article/view/582</self-uri><abstract><p>Проведены предварительные поисковые исследования в области синтеза производных из группы пирролопиридинов, обладающих биологической активностью. Предложен механизм реакции с использованием принципа домино-реакций. Структура полученных соединений установлена физико-химическими методами. Синтезированные бензиловый эфир 5-трет-бутил-1-бензил-2,4-диоксогексагидро-1Н-пирроло[3,2]пиридин-3а,5-(6Н)-дикарбоксилата и бензиловый эфир 5-трет-бутил-2,4-диоксо-1-фенэтилгексагидро-1Н-пирроло[3,2с]-3а,5(6Н)-дикарбоксилата выделены методом колоночной хроматографии (адсорбент - силикагель), чистота продуктов на этапах очистки контролировались методом тонкослойной хроматографии [ТСХ, элюент - циклогексан : ацетон (3:2), сорбент на пластинках Silufol - силикагель].</p></abstract><trans-abstract xml:lang="en"><p>The pilot studies on derivative synthesis based on pyrrolo-pyridine and pyrrolo-pyrrole groups possessing pharmacological activity have been conducted. Domino reactions principle has been used during the studies. The possibility of physico-chemical methods appliance has been studied in order to standardize the obtained chemical compounds. Synthesized benzyl ether 5-tert-butyl-1-benzyl-2,4-dioxohexahydro-1H-pyrrolo[3,2]pyridine-3a,5-(6H)-dicarboxylate and benzyl ether 5-tert-butyl-2,4-dioxo-1-phenethylhexahydro-1H-pyrrolo[3,2c]-3a,5(6H)-dicarboxylate were isolated by column chromatography (adsorbent - silica gel). The purity of products were monitored by TLC (thin layer chromatography) during the purification steps, eluent cyclohexane:acetone=3:2, sorbent on Silufol silica gel plates.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>пирролопиридины</kwd><kwd>синтез</kwd><kwd>домино-реакции</kwd><kwd>анализ</kwd><kwd>биологически активные соединения</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pyrrolopyridines</kwd><kwd>synthesis</kwd><kwd>pyrrolo-pyrroles</kwd><kwd>analysis</kwd><kwd>pharmacologically active compounds</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">E. Martini, L. Di Cesare Mannelli, G. Bartolucci. Synthesis and biological evaluation of 3,7-diazabicyclo[4.3.0]nonan-8-ones as potential nootropic and analgesic drugs // J. Med. Chem. 2011. V. 54. P. 2512-2516.</mixed-citation><mixed-citation xml:lang="en">E. Martini, L. Di Cesare Mannelli, G. Bartolucci. Synthesis and biological evaluation of 3,7-diazabicyclo[4.3.0]nonan-8-ones as potential nootropic and analgesic drugs // J. Med. Chem. 2011. V. 54. P. 2512-2516.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">S.K. Shan, N. Chen. Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors // Bioorganic and Medicinal Chemistry Letters. 2005. V. 15. P. 977-982.</mixed-citation><mixed-citation xml:lang="en">S.K. Shan, N. Chen. Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors // Bioorganic and Medicinal Chemistry Letters. 2005. V. 15. P. 977-982.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">M. Ecija, A. Diez, M. Rubiralta, N. Casamitjana. Synthesis of 3-aminolactams as X-Gly constrained pseudodipeptides and conformational study of a Trp-Gly surrogate // J. Org. chem. 2003. V. 68. P. 9541-9553.</mixed-citation><mixed-citation xml:lang="en">M. Ecija, A. Diez, M. Rubiralta, N. Casamitjana. Synthesis of 3-aminolactams as X-Gly constrained pseudodipeptides and conformational study of a Trp-Gly surrogate // J. Org. chem. 2003. V. 68. P. 9541-9553.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
